Remimazolam anesthesia to prevent kidney injury after liver or pancreas surgery
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is testing whether the anesthesia drug remimazolam can help protect your kidneys after liver or pancreas surgery. It's comparing it to a standard anesthesia drug to see if it reduces the chances of kidney injury after the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 84 years old
- You are having elective (planned) surgery on your liver or pancreas
- You are in generally good health (classified as ASA grade 1-3)
- You do not have chronic kidney disease
- You are not allergic to the anesthesia medications used in this trial
- You do not have severe liver, brain, eye, or breathing conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study compares two types of anesthesia to see which one better preserves brain function and recovery after laparoscopic gallbladder removal. It aims to help patients wake up more clearly and maintain cognitive function after surgery.
This study tests a medicine called remimazolam to see if it reduces confusion and agitation (emergence delirium) when children wake up from brain surgery. It may help your child have a smoother recovery.
This trial tests whether a medication called remimazolam can help prevent atrial fibrillation—a common, irregular heart rhythm that can happen after surgery. It focuses on people having a specific planned type of heart bypass surgery and checks if the study medication reduces postoperative rhythm problems.
This trial tests whether using remimazolam or propofol during hip or knee replacement surgery can lower the risk of postoperative delirium, a sudden, short-term confusion that can happen after anesthesia. It may help people who are at higher risk of postoperative confusion by finding the safer anesthesia approach.
Hear when a new Remimazolam trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.